USE OF VAP-1 INHIBITORS FOR FIBROTIC SICKNESS TREATMENT Russian patent published in 2016 - IPC A61K39/395 

FIELD: bioengineering.

SUBSTANCE: invention relates to the method of medical treatment of human fibrotic sicknesses, including the injection to the said patient of an effective quantity of a VAP-1 inhibitor, when the said VAP-1 inhibitor is selected from the group comprising anti-VAP-1-of antibodies and SSAO inhibitors, where the said SSAO inhibitor is selected from hydrazine derivatives, derivatives of 4,5,6,7-tetrahydroimidazo[4,5-c]pyridine, thiocarbamoyl derivatives, carboxamides, sulphonamides, thiazols, including derivatives of guanidine, oxime derivatives, dihydrazine, arylalkylamines, oxazolidinones, halogenalkylamines, benphotiamine derivatives, and imidazopyridine derivatives.

EFFECT: invention is effective for the medical treatment of fibrotic sicknesses.

5 cl, 19 dwg, 7 tbl, 8 ex